Ozempic's meteoric rise has reshaped the landscape of healthcare, retail, and consumer behavior. Its initial popularity as a weight loss medication has sparked a broader conversation around health, wellness, and body image.
Earlier this month, a district court in Texas issued a nationwide preliminary injunction against enforcement of the Corporate Transparency Act (“CTA”).
In November, we wrote about Massachusetts legislative and regulatory updates that impact both nursing homes and assisted living residences.... By: ArentFox Schiff
Earlier this week, efforts to reduce U.S. reliance on biotechnology companies in China stalled when the BIOSECURE Act (“BIOSECURE” or the “Act”) was left out of this week’s continuing resolution (CR). As a result, BIOSECURE will not be enacted into law this year.
On December 18, 2024, the European Data Protection Board (EDPB) issued an opinion on personal data use in artificial intelligence (AI) in response to the Irish Data Protection Commission's request for more clarity regarding how the EU General Data Protection Regulation (GDPR) applies to AI....
The Hong Kong Stock Exchange concluded its consultation on proposed amendments to the Corporate Governance Code and related Listing Rules. All proposals were adopted with certain modifications and clarifications and will go into effect on July 1, 2025....
The High Court ruled that companies can assert privilege against their shareholders, rejecting the “Shareholder Rule” which had been alluded to in some previous authorities.
The MTV reality series The Real World ended their opening intro with “to find out what happens… when people stop being polite… and start getting real.” As an ERISA attorney working with retirement plan clients, I often find that what determines a good third-party administrator (TPA) from a bad on
